Clinical trial
A Multicenter Prospective-Retrospective Real-World Study Evaluating Conversion-to-Surgery and Survival After Genotype-Matched Neoadjuvant Systemic Therapy in Locally Advanced Thyroid Carcinoma
NCT07010393 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Prospective-Retrospective Real-World Study Evaluating Conversion-to-Surgery and Survival After Genotype-Matched Neoadjuvant Systemic Therapy in Locally Advanced Thyroid Carcinoma
- Lead sponsor
- Fujian Medical University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 335 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.